Now accepting Scholarship Applications. All applications must be post marked by April 3, 2020
Odenville Drugs Logo

Get Healthy!

Results for search "Vaccines".

Show All Health News Results

Health News Results - 280

President-elect Joe Biden described an ambitious national vaccination plan on Friday that will deliver coronavirus vaccines to far more people and invoke a wartime law to boost vaccine production.

In a speech in Delaware, Biden told Americans that, "The honest truth is this: Things will get worse before they get better."

He pledged to ramp up vaccination availability in pharmacies, ...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 16, 2021
  • |
  • Full Page

President-elect Joe Biden proposed a $1.9 trillion coronavirus "rescue" plan on Thursday that would pump $400 billion directly into efforts to fight the pandemic, with the rest focused on economic relief and state and local aid.

""I know what I just described will not come cheaply," Biden said during a speech Thursday night. "But failure to do so will cost us dearly. The crisis of deep hu...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 15, 2021
  • |
  • Full Page


Now that federal guidelines have expanded COVID-19 vaccine eligibility to include people over 65 and those of all ages with underlying health conditions, drug stores say they are ready, willing and able to start giving the shots.

There's just one slight glitch: supply. But with two vaccines already available and others moving toward emergency use authorizati...

The United States has far fewer flu cases than normal, and experts say it's probably due to measures people are taking to protect themselves from COVID-19.

Flu season usually peaks between December and February. Influenza typically causes about 45 million illnesses, 810,000 hospitalizations and 61,000 deaths in the United States each year, according to the U.S. Centers for Disease Control...

U.S. President-elect Joe Biden's target of 100 million COVID-19 vaccinations delivered within the first 100 days of his administration isn't just a lofty goal, two members of his pandemic advisory board said Thursday.

Rather, it's a hard-nosed response to the daily toll that the coronavirus takes on American lives.

"We understand the gravity of the situation," said board member Dr. ...

Folks who've gotten through a COVID-19 infection might naturally question whether they need to get a coronavirus vaccination when their turn comes.

Experts say they really need the shot anyway, because even after having COVID they might be vulnerable to reinfection.

"We're encouraging people if they meet the other criteria to get immunized because we don't know how long either natur...

One month after the United States began what has become a troubled rollout of a national COVID vaccination campaign, the effort is finally gathering real steam.

Close to a million doses -- over 951,000, to be more exact -- made their way into the arms of Americans in the past 24 hours, the U.S. Centers for Disease Control and Prevention reported Wednesday. That's the largest number of sho...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 14, 2021
  • |
  • Full Page

WEDNESDAY, Jan. 13, 2021 -- A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts.

The vaccine produced an immune response of all 805 clinical trial participants within two months of inoculation, according to results published Jan. 13 in the New England Journal...

Coronavirus deaths in the United States hit another daily record on Tuesday, with 4,400 Americans succumbing to COVID-19 in the last 24 hours.

The United States already has the world's highest death tally by a wide margin, and is only about 20,000 shy of 400,000 just one month after the country crossed the 300,000 threshold, The New York Times reported.

In a change that il...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 13, 2021
  • |
  • Full Page


People who began having oral sex at a young age or at greater "intensity" may face an increased risk of a type of throat cancer, a new study finds.

The study, published online Jan. 11 in the journal Cancer, focused on oropharyngeal cancer caused by human papillomavirus (HPV). The sexually transmitted infection can, in a small number of peo...

President-elect Joe Biden received his second dose of a coronavirus vaccine on Monday and announced that he plans to outline more of his pandemic response plan on Thursday.

Biden got his first shot of the Pfizer vaccine on Dec. 21. Since then, about 60,000 more Americans have died from COVID-19, the Associated Press reported.

The Pfizer vaccine requires a second shot about...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 12, 2021
  • |
  • Full Page

As the rollout of the COVID-19 vaccines continues, scores of questions are emerging. Here, experts from Penn State Health answer some of the more common ones.

How do the COVID-19 vaccines work?

The COVID-19 vaccines work by teaching the immune system to protect against the virus, experts said.

Neither of the two vaccines approved in the United States -- made ...

U.S. health officials raced to ramp up the delivery of COVID-19 vaccines across the country as both coronavirus case counts and death tallies continued to hit record highs.

"We really need to get this vaccine out more quickly, because this is really our only tool," Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, told CBS's Face the Natio...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 11, 2021
  • |
  • Full Page

A task force of allergists and immunologists recommends those administering the COVID-19 vaccine ask patients some key questions beforehand.

While reactions to vaccines are extremely rare, the American College of Allergy, Asthma and Immunology (ACAAI) said anyone being vaccinated should be asked if they have a history of a severe allergic reaction ...

President-elect Joe Biden plans to release nearly all available doses of COVID-19 vaccine when he takes office, reversing the Trump administration's strategy of holding back half the supply to ensure second doses are available.

The potentially risky move is meant to boost a nationwide COVID-19 vaccination program that has gotten off to a slow start, with only about 5.9 million doses admin...

As Americans await their COVID-19 shot, a new study of a different vaccine shows the power of Facebook posts in fueling "anti-vax" resistance to immunization.

The study included more than 10 years of public Facebook posts on the human papillomavirus (HPV) vaccine. It found that nearly 40% of 6,500 HPV vaccine-related posts from 2006 to 2016 amplified a perceived risk. The data suggest the...

A record-shattering number of coronavirus infections and deaths were reported Thursday in the United States, as health officials fretted about a new, more contagious variant that has now been detected in eight states.

The grim statistics? At least 280,000 new cases and more than 4,000 deaths on Thursday, according to The New York Times.

There was a glimmer of good news, ho...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 8, 2021
  • |
  • Full Page

Cases of anaphylactic shock caused by COVID-19 vaccines are very rare, based on numbers from the first week and a half of vaccinations in the United States, federal public health officials said Wednesday.

There have been 21 cases of anaphylaxis out of nearly 1.9 million doses of the Pfizer-BioNTech vaccine administered in the very first days of the national COVID-19 vaccination program, s...

A return to normal life in America might happen sooner than many expect, one of the nation's leading vaccine experts told HD Live! this week.

As the new coronavirus rages across the country, President-elect Joe Biden has set a goal of one million doses of vaccine delivered every day once he takes office. If that ambitious target is realized, everyday conditions in the United States might ...

As COVID-19 spreads across the country and vaccines are not yet widely available, it's important to plan for what you would do if you become infected with the virus, says a psychologist who's counseled critically ill and recovering patients.

"We can't let our guard down while we wait our turn for the vaccine," said rehabilitation psychologist Abigail Hardin, from Rush University Medic...

By Nov. 15 of last year, roughly 47 million Americans -- about 14.5% of the U.S. population -- had already been infected with the new coronavirus, a new study finds.

That's much higher than the close to 11 million known U.S. cases of infection that were recorded by that date, the researchers said, because reported cases "do not represent the full SARS-CoV-2 disease burd...

Two top officials at the U.S. Food and Drug Administration said Monday that any American who gets the Moderna or Pfizer coronavirus vaccines must get two full doses, despite international debate on possible ways to stretch vaccine supply.

"We have been following the discussions and news reports about reducing the number of doses, extending the length of time between doses, changing the do...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 5, 2021
  • |
  • Full Page

The two COVID-19 vaccinations approved by the U.S. Food and Drug Administration are safe and effective even for people with food or medication allergies, allergists say.

Some allergic reactions in Britain raised concerns, which led Dr. Aleena Banerji, head of the allergy and clinical immunology unit at Massachusetts General Hospital, and her colleagues to review all that's known about al...

As U.S. officials ramped up efforts to vaccinate more Americans, scientists around the world wrestled with whether it would make sense to delay the second doses everyone will need so more people can be vaccinated more quickly.

Since even the first shot offers some protection, there are experts who believe that the fastest way to get the pandemic under control is to give first injections a...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • January 4, 2021
  • |
  • Full Page

THURSDAY, Dec. 31, 2020 -- Folks who contract COVID-19 can expect to gain some durable immunity against future infection, according to a new study of memory cells within the immune systems of coronavirus patients.

Previous studies have raised concern that COVID-19 patients might lose their immunity quickly once they recover, because the first wave of coronavirus antibodies tends to wane a...

Even though 11.4 million doses of the approved Pfizer and Moderna COVID-19 vaccines had been distributed across the United States by Monday morning, just 2.1 million had made it into the arms of high-risk Americans.

That's far too slow a pace, said one official charged with spearheading the vaccination of Americans.

"We agree that that number is lower than what we hoped for," Monce...

THURSDAY, Dec. 31, 2020 -- A new and more infectious variant of the COVID-19 virus has shown up in separate cases in Colorado and California, weeks after it first emerged in the United Kingdom.

Doctors on the pandemic's front line say people shouldn't panic, but should definitely adhere even more closely to proven infection control measures, like mask wearing and social distancing.

...

The first recorded case of a faster-spreading variant of the new coronavirus has been detected in a 20-year-old man in Colorado, Gov. Jared Polis said Tuesday.

The young man carries a variant of the virus that is thought to be more contagious -- but not more lethal -- than variants previously circulating globally this year.

The rapid spread of the new variant within Britain has ...

Vaccine maker Novavax, along with federal health researchers, announced Monday that a phase 3 trial will begin on the safety and effectiveness of another COVID-19 vaccine -- the fifth shot to reach this final stage of development.

"We've come this far, this fast, but we need to get to the finish line," Dr. Francis Collins, director of the U.S. National Institutes of Health (NIH), said in...

When queried in polls conducted earlier this year, only about half of American adults said they planned to get any vaccine against the new coronavirus. But after a largely successful rollout this month of two safe and effective shots, many of those initial doubters now say they'll line up to get their vaccine doses when their turn comes.

According to The New York Times, polls con...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • December 28, 2020
  • |
  • Full Page

WEDNESDAY, Dec. 23, 2020 (Healthday News) -- Pfizer Inc. and the Trump Administration were close to a deal on Tuesday that would get more of the company's coronavirus vaccine to Americans in the coming year.

Such an agreement would help the United States manage a coming vaccine shortage that could leave up to 110 million Americans uncovered in the first half of 2021, The New York Time...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • December 23, 2020
  • |
  • Full Page

In very rare cases, some people have had severe allergic reactions after receiving the new COVID-19 vaccines, leading the American College of Allergy, Asthma, and Immunology (ACAAI) to issue updated guidance for Americans with allergies.

The U.S. Food and Drug Administration has given emergency use authorization to COVID-19 vaccines from Pfizer-BioNTech and Moderna.

The ACAAI's COVI...

MONDAY, Dec. 21, 2020 (Healthday News) -- Even as U.S. experts announced Sunday which Americans will be next in line receive a COVID-19 vaccine, health officials worldwide worried about a new strain of coronavirus that appears to spread faster than before.

In the United States, the Centers for Disease Control and Prevention's vaccine advisory committee voted to recommend that those over 7...

There's a lot of misinformation about vaccines as the United States begins its massive COVID-19 vaccination program, so an expert wants to dispel the many myths about vaccines in general.

Vaccines are among the most heavily studied of all drugs, and the evidence shows they are safe and extremely effective, according to Dr. Patrick Gavigan, a pediatric infectious disease physician at Penn ...

SATURDAY, Dec. 19, 2020 (Healthday News) -- Moderna's coronavirus vaccine was granted emergency use approval by the U.S. Food and Drug Administration on Friday, and it will now join Pfizer's vaccine in an unprecedented national campaign to inoculate enough Americans to stem the spread of COVID-19.

"With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken...

Though many Americans would support a COVID-19 vaccine mandate, a Gallup survey finds there is no clear majority in favor of it.

The Gallup Panel conducted the online survey of 2,730 U.S. adults between Sept. 14 and 27.

Nearly 49% of respondents said they would "accept" a state mandate requiring children to be vaccinated in order to attend school. But support fell to 41% when respo...

FRIDAY, Dec. 18, 2020 (Healthday News) -- The U.S. Food and Drug Administration said Thursday night that it will move quickly to authorize the emergency use of Moderna's coronavirus vaccine after one of its advisory panels voted to give its blessing to the shot.

"Following today's positive advisory committee meeting outcome regarding the Moderna COVID-19 vaccine, the U.S. Food and Drug Ad...

THURSDAY, Dec. 17, 2020 (Healthday News) -- The U.S. Food and Drug Administration said Wednesday that additional doses can be drawn from vials of Pfizer's coronavirus vaccine, after pharmacists noticed the vials contained more than the expected five doses.

The discovery could expand the country's supply by millions of doses just as the Trump administration negotiates with Pfizer to speed...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • December 17, 2020
  • |
  • Full Page

WEDNESDAY, Dec. 16, 2020 (Healthday News) -- The Trump administration is working to free up raw materials that Pfizer requires to make tens of millions more doses of its coronavirus vaccine in the first half of 2021.

Should an agreement be struck with the company, it could help ease a future shortage that will come because the White House did not pre-order more doses of the Pfizer vaccine...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • December 16, 2020
  • |
  • Full Page

It will be tempting for folks to think they can resume a "normal" life after they've received the two-dose course of the COVID-19 vaccine.

But infectious disease experts warn that you'll still need to wear a mask and practice social distancing even after getting either the Pfizer or Moderna vaccines, or perhaps one of the other vaccines still in the testing pipeline.

That's because ...

Amid hopes stirred by the recent rollout of an approved COVID-19 vaccine in the United States, a new study warns that shots may not be available to nearly one-quarter of the world's people until 2022.

A second study estimates that 3.7 billion adults worldwide are willing to get the vaccine.

Together, these two findings suggest that getting people immunized could be as big a challen...

As America rolls out a nationwide coronavirus vaccination campaign this week, experts help answer your questions about the new COVID-19 vaccines.

Both the Pfizer vaccine (already approved by the U.S. Food and Drug Administration) and the Moderna vaccine (up for approval) were developed using a technology called messenger RNA, or mRNA, explained Dr. Thomas Ma. He's chair of the department ...

TUESDAY, Dec. 15, 2020 (Healthday News) -- The number of Americans killed by the new coronavirus topped 300,000 on Monday, the same day the country launched a massive vaccination campaign to curb the spread of COVID-19.

And on Tuesday morning, scientists from the U.S. Food and Drug Administration released a data review that almost guarantees a second vaccine will soon join the Pfizer vacc...

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • December 15, 2020
  • |
  • Full Page

Americans may have questions about possible allergic reactions as immunization with the first COVID-19 vaccine begins, and allergy experts can provide some answers.

The Pfizer COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration on Friday, and distribution of the vaccine began on Monday. But on Dec. 9, soon after the rollout of the vaccine in t...

MONDAY, Dec. 14, 2020 (Healthday News) -- The first shipments of nearly 3 million doses of the Pfizer coronavirus vaccine were on their way to hospitals in all 50 U.S. states on Sunday, as the country began an unprecedented effort to inoculate enough Americans to stop the spread of COVID-19.

Gen. Gustave F. Perna, chief operating officer of the federal effort to develop a vaccine, told

  • Ernie Mundell and Robin Foster HealthDay Reporters
  • |
  • December 14, 2020
  • |
  • Full Page

The U.S. Food and Drug Administration approved Pfizer's coronavirus vaccine for emergency use on Friday, clearing the way for the launch of a national campaign to inoculate enough Americans to stem the spread of COVID-19.

In what looks like a powerful turning point in the pandemic, the United States becomes the sixth country -- in addition to Britain, Bahrain, Canada, Saudi Arabia and Mex...

More than 15 million Americans have been infected by the COVID-19 virus, and many may be questioning whether they need to receive one of the two coronavirus vaccines now on the verge of approval from U.S. regulators.

Short answer: Yes.

"They will be asked to stand in line and get a vaccine also," said Dr. William Schaffner, a professor of infectious diseases at Vanderbilt University...

The U.S. Food and Drug Administration is expected to approve emergency use of Pfizer's coronavirus vaccine as early as Saturday after its advisory panel cleared the way for the start of a national campaign to inoculate Americans and stem the spread of COVID-19.

That means the first vaccinations will likely begin early next week, The New York Times reported. Who is first in line? ...

A U.S. Food and Drug Administration advisory panel will vote on Thursday whether to recommend emergency approval of Pfizer's coronavirus vaccine, a decision that will come not a moment too soon as the country reported more than 3,000 new COVID-19 deaths on Wednesday.

That record-breaking statistic is unlikely to drop significantly anytime soon: The number of people hospitalized with COVID...

AstraZeneca's COVID-19 vaccine is safe and effective, new data from late-stage trials shows.

Overall, the vaccine protected against symptomatic disease in 70% of cases, according to a team led by researchers from Oxford University in England. Among study volunteers who got a half dose and then a full dose, the rate was 90%, while the rate was 62% in those given two full doses.

Show All Health News Results